Literature DB >> 15953070

Identification of a recurrent mutation in the human hairless gene underlying atrichia with papular lesions.

M Massé1, A Martinez-Mir, H Lam, M T Geraghty, A M Christiano.   

Abstract

Identification of mutations in the hairless (HR) gene in patients with atrichia with papular lesions (APL) has proven of critical importance, as it provides a basis for the differentiation between APL and alopecia universalis. The establishment of the diagnostic criteria for APL has triggered the identification of a large number of APL patients among those suspected to suffer from alopecia universalis. This advancement has resulted in the discovery of an increasing number of hairless mutations in both consanguineous and nonconsanguineous APL families. Here, we report the identification of a homozygous mutation, 3434delC, in an APL patient of Arab-Palestinian descent. The proband is a 23-year-old female with generalized scalp and body alopecia. To confirm the diagnosis of APL and to identify the specific mutation, we sequenced the hairless gene. Sequencing of all exons of the hairless gene revealed a homozygous frameshift mutation, 3434delC, in exon 18. Interestingly, the same mutation was previously identified in an Arab-Israeli family. Our data suggest that the 3434delC mutation most likely represents a founder mutation in this geographical region.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15953070     DOI: 10.1111/j.1365-2230.2005.01762.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Mutations in the hairless gene underlie APL in three families of Pakistani origin.

Authors:  Liv Kraemer; Muhammad Wajid; Yutaka Shimomura; Angela M Christiano
Journal:  J Dermatol Sci       Date:  2008-04       Impact factor: 4.563

2.  Nonsense mutations in the hairless gene underlie APL in five families of Pakistani origin.

Authors:  Hyunmi Kim; Muhammad Wajid; Liv Kraemer; Yutaka Shimomura; Angela M Christiano
Journal:  J Dermatol Sci       Date:  2007-09-14       Impact factor: 4.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.